- In April 2023, Johnson & Johnson MedTech (Ethicon) announced the launch of its innovative ENSEAL X1 Curved Jaw Tissue Sealer, designed to enhance precision and control in laparoscopic and open surgical procedures. This advancement, while not directly biohybrid, represents continuous innovation in surgical instrumentation crucial for highly precise medical interventions, a foundational aspect for future biohybrid systems
- In March 2023, Intuitive Surgical, Inc., a global leader in robotic-assisted surgery, announced the first cases performed with its da Vinci SP surgical system in specific thoracic procedures in Japan. This expansion highlights the continuous advancement and adoption of sophisticated robotic platforms in medical applications, which are often the deployment vehicles for future biohybrid components
- In March 2023, Medtronic plc continued to highlight the global expansion and clinical utilization of its Hugo Robotic-Assisted Surgery (RAS) system, with increasing installations and procedures worldwide. Medtronic's investments in robotic surgery platforms contribute to the infrastructure and technological base that could eventually integrate biohybrid elements for enhanced surgical capabilities
- In February 2023, Microbot Medical Inc., a company focused on robotic technologies for medical applications, announced progress in its clinical trials for the LIBERTY Robotic System, designed for neurovascular interventions. While not purely biohybrid, this demonstrates advancements in miniaturized robotics for navigating complex human anatomy, a key challenge also addressed by biohybrid approaches
- In January 2023, Stryker Corporation continued to report on the strong adoption of its Mako SmartRobotics system for orthopedic procedures, showcasing its expansion into new hospitals and increased procedural volumes. Stryker's continuous innovation in orthopedic robotics, including advancements in haptics and precision, lays groundwork for future integration with biological elements
